Found a sample of hepatitis C vaccine

A team of researchers at the University of Alberta, Canada has announced that a vaccine strain has been found to be able to fight almost all hepatitis C viruses, which harm 200 million people around the world and so far have not been There are special vaccines.

>>>There is going to be a hepatitis C vaccine

Lead researcher, Michael Houghton, who led the research team to find the hepatitis C virus in 1989, announced his results at the new Summit of Presidents of the Canadian Research Talents Group on February 16. here.

Although the hepatitis A and B vaccines have been built for a long time, the development of the hepatitis C vaccine so far is still a huge challenge. Hepatitis C is actually more harmful than HIV in that it has all six basic strains of viruses and hundreds of other subtypes, making it possible to develop a single vaccine that is resistant to all strains of the virus. Science thinks it's impossible.

John Law, a researcher in the team that developed the vaccine
Gan C University of Alberta, Canada. (Photo: Medicalxpress)

Surprisingly, the vaccine is made from a single strain of the virus and after testing over 60 healthy people, the vaccine has the ability to make the body produce antibodies that neutralize all major viral bacteria. That is, this single vaccine can treat a range of current hepatitis C viruses, potentially treating all hepatitis C viruses.

'The new discovery shows that a vaccine made from a single strain can neutralize all different strains of the virus, ' said Houghton. 'This is a big step in the hepatitis vaccine industry.' Future promising results for people with hepatitis C and those who live or travel to areas of viral spread.

However, University of Alberta researchers also note that they still need deeper experiments. Specifically, 'it is not certain whether the recipient body produces antibodies that can neutralize the main virus strain and if these antibodies can, the scale of the deactivation process how big will it be? ' . In addition, it may take another 5 to 7 years for this vaccine to be mass produced.

Houghton spent more than 10 years developing this vaccine, starting when he worked at a pharmaceutical company.